REISTONE BIOPHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Jul 2023)
What this means for you
This application is over — abandoned 24 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90701198
- Mark type
- Stylized text
- Filed
- 10 May 2021
- Published for opposition
- 25 Oct 2022
- Abandoned
- 24 Jul 2023
- Attorney of record
- Jessica R. Manganello
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Therapeutic pharmaceutical for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders
Owner
- Reistone Biopharma, Inc., Rosemont, IL, US
- Reistone Biopharma, Inc., Rosemont, IL, US
Prosecution history
- 24 Jul 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Jul 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Oct 2022 — PUBLISHED FOR OPPOSITION
- 05 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Aug 2022 — ASSIGNED TO LIE
- 18 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Jul 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Jul 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED